Finance

Beta
Lists
MRCK34:BVMF
Merck BDR
72,19 R$
0,00%
(0,00) 1D
1 ივნ, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for MRCK34...
Open
74,23 R$
High
74,23 R$
Low
71,91 R$
Mkt. cap
284,45 მლრ.
Avg. vol.
2,89 ათ.
Volume
4,17 ათ.
52-wk high
80,07 R$
52-wk low
51,31 R$
Shares outstanding
2,47 მლრდ.
No. of employees
74 ათ.
Open
74,23 R$
High
74,23 R$
Low
71,91 R$
Mkt. cap
284,45 მლრ.
Avg. vol.
2,89 ათ.
Volume
4,17 ათ.
52-wk high
80,07 R$
52-wk low
51,31 R$
Shares outstanding
2,47 მლრდ.
No. of employees
74 ათ.
News stories
From sources across the web
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck BDR
CEOრობერ ემ დავის
Employees74 ათ.
Founded1 იან. 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
15,81 მლრდ.
17,28 მლრდ.
16,40 მლრდ.
16,29 მლრდ.
Cost of goods sold
3,39 მლრდ.
3,74 მლრდ.
4,30 მლრდ.
3,88 მლრდ.
Cost of revenue
3,39 მლრდ.
3,74 მლრდ.
4,30 მლრდ.
3,88 მლრდ.
Research and development expenses
4,00 მლრდ.
4,00 მლრდ.
4,00 მლრდ.
3,56 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,50 მლრდ.
2,48 მლრდ.
2,73 მლრდ.
2,57 მლრდ.
Operating expense
6,49 მლრდ.
6,48 მლრდ.
6,73 მლრდ.
6,12 მლრდ.
Total operating expenses
9,88 მლრდ.
10,23 მლრდ.
11,02 მლრდ.
10,00 მლრდ.
Operating income
5,92 მლრდ.
7,05 მლრდ.
5,38 მლრდ.
6,29 მლრდ.
Other non operating income
69,00 მლნ.
-
41,00 მლნ.
42,00 მლნ.
EBT including unusual items
5,00 მლრდ.
6,74 მლრდ.
3,42 მლრდ.
-3,53 მლრდ.
EBT excluding unusual items
5,68 მლრდ.
6,76 მლრდ.
4,98 მლრდ.
5,85 მლრდ.
Income tax expense
571,00 მლნ.
958,00 მლნ.
458,00 მლნ.
709,00 მლნ.
Effective tax rate
11,42%
14,20%
13,39%
-20,06%
Other operating expenses
-
-
-
-
Net income
4,43 მლრდ.
5,78 მლრდ.
2,96 მლრდ.
-4,24 მლრდ.
Net profit margin
28,01%
33,49%
18,07%
-26,03%
Earnings per share
2,13
2,58
2,04
-1,28
Interest and investment income
69,00 მლნ.
96,00 მლნ.
69,00 მლნ.
35,00 მლნ.
Interest expense
-305,00 მლნ.
-327,00 მლნ.
-411,00 მლნ.
-479,00 მლნ.
Net interest expenses
-236,00 მლნ.
-231,00 მლნ.
-342,00 მლნ.
-444,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
6,99 მლრდ.
8,15 მლრდ.
6,79 მლრდ.
7,69 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer